Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Barinthus Biotherapeutics (BRNS) Depreciation and Depletion (2022 - 2026)

Barinthus Biotherapeutics filings provide 5 years of Depreciation and Depletion readings, the most recent being $200000.0 for Q1 2026.

  • On a quarterly basis, Depreciation and Depletion fell 83.33% to $200000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $1.8 million, a 43.75% decrease, with the full-year FY2025 number at $2.9 million, up 11.54% from a year prior.
  • Depreciation and Depletion hit $200000.0 in Q1 2026 for Barinthus Biotherapeutics, down from $300000.0 in the prior quarter.
  • In the past five years, Depreciation and Depletion ranged from a high of $1.2 million in Q1 2025 to a low of $100000.0 in Q3 2025.
  • Median Depreciation and Depletion over the past 5 years was $500000.0 (2023), compared with a mean of $529411.8.
  • Biggest five-year swings in Depreciation and Depletion: surged 150.0% in 2023 and later plummeted 85.71% in 2025.
  • Barinthus Biotherapeutics' Depreciation and Depletion stood at $300000.0 in 2022, then surged by 133.33% to $700000.0 in 2023, then dropped by 14.29% to $600000.0 in 2024, then crashed by 50.0% to $300000.0 in 2025, then tumbled by 33.33% to $200000.0 in 2026.
  • The last three reported values for Depreciation and Depletion were $200000.0 (Q1 2026), $300000.0 (Q4 2025), and $100000.0 (Q3 2025) per Business Quant data.